Advances in sequencing technology have made multigene testing, or “panel testing,” a practical option when looking for genetic variants that may be associated with a risk of breast cancer. In June
Insight into genetic susceptibility to male breast cancer by multigene panel testing: Results from a multicenter study in Italy - Rizzolo - 2019 - International Journal of Cancer - Wiley Online Library
Genetic assessments of breast cancer risk that do not account for polygenic background are incomplete and lead to incorrect preventative strategies
BREAST CANCER. END OF ERA FOR BRCA1 / 2 AND NGS PANELS. NEW ERA with POLYGENIC RISK
Frontiers Case Report: Detection of a Novel Germline PALB2 Deletion in a Young Woman With Hereditary Breast Cancer: When the Patient's Phenotype History Doesn't Lie
FDA Authorizes First Genetic Test to Assess Risk of Multiple Cancers
Interplay of Mendelian and polygenic risk factors in Arab breast cancer patients, Genome Medicine
Breast Cancer - Expanded Risk Panel Test - PreventionGenetics
Frontiers Peripheral Blood-Based Biopsy for Breast Cancer Risk Prediction and Early Detection
BOADICEA: a comprehensive breast cancer risk prediction model incorporating genetic and nongenetic risk factors
